Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction
Investigative Ophthalmology & Visual Science · 02.11.2026 · 67 (13) · 4
DOI: 10.1167/iovs.67.13.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 02.11.2026. Verfasst von Yang Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Proteomics, Meibomian Gland Dysfunction, Inflammation, Meibomian Glands. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
Zitieren
APA
Lu, Y., & Gong, L. (2026). Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction. Investigative Ophthalmology & Visual Science, 67(13), 4. https://doi.org/10.1167/iovs.67.13.4
Vancouver
Lu Y, Gong L. Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction. Investigative Ophthalmology & Visual Science. 2026;67(13):4. doi:10.1167/iovs.67.13.4
BibTeX
@article{Lu2026,
author = {Lu, Yang and Gong, Lan},
title = {Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
volume = {67},
number = {13},
pages = {4},
doi = {10.1167/iovs.67.13.4}
}
EUVIMED